Michael Pisetsky, an officer at SI-BONE, Inc., has filed to sell more than 36,000 shares of the company as part of a planned sale under Rule 144. This filing, dated November 4, 2026, is significant as it reflects both the personal financial strategies of company executives and the broader trends within the surgical and medical instruments industry.
SI-BONE, Inc. is a company focused on developing innovative solutions for patients with musculoskeletal disorders. The company operates under the Standard Industrial Classification (SIC) code for Surgical & Medical Instruments & Apparatus. Its recent filings indicate a commitment to growth and innovation in a competitive marketplace.
According to the filing, Pisetsky plans to sell 36,241 shares, which he acquired through a combination of restricted stock units and the exercise of stock options. The total market value of the shares is approximately $861,448.57. The filing states, "The securities to be sold were acquired upon the vesting of restricted stock units during the period of 07/23/2018 through 1/1/2026." This indicates a strategic move to liquidate some of his holdings while still maintaining a stake in the company.
The filing also notes that Pisetsky's previous sales in the last three months included over 29,000 shares sold on October 29, 2026, generating gross proceeds of $655,743.37. Such transactions may influence investor sentiment and the stock's performance, especially as they reflect the actions of key company executives.
This move could have implications for both the company and the industry at large. Executives selling shares can sometimes signal confidence in the company's future, but it can also raise questions about their commitment to the company. As SI-BONE continues to innovate and expand, other industry players may closely monitor these developments to gauge market trends.
Looking ahead, it remains to be seen how this sale will impact SI-BONE's stock performance and investor relations. The filing does not specify any further actions or upcoming events related to this transaction.
Read Next
FTC Solar resumes at-the-market offering program
BofA Finance LLC files pricing supplement for callable yield notes
Citigroup files preliminary pricing for new financial product
Lloyds Banking Group Issues $1.25 Billion Senior Notes
T. Rowe Price Private Opportunities Offshore Fund updates filing
Nicola Santoro Jr. files to sell 100,000 shares of Rithm Capital










